胃癌患者-话题@MedSci

#胃癌患者#

108篇内容 | 1275人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1769714, encodeId=b5711e697148b, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=BMC Cancer：多中心倾向匹配分析比较术前 vs 术后放化疗治疗局部进展胃癌患者的疗效, objectType=article, longId=299728, objectId=d846299e2851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d846299e2851, replyNumber=0, likeNumber=31, createdTime=2023-02-08, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d846299e2851, moduleTitle=BMC Cancer：多中心倾向匹配分析比较术前 vs 术后放化疗治疗局部进展胃癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d846299e2851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769718, encodeId=e5ea1e6971881, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=JAMA子刊：推荐局部晚期胃癌患者采用腹腔镜手术治疗，效果优异、并发症少！, objectType=article, longId=733744, objectId=5b82e33744f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b82e33744f2, replyNumber=0, likeNumber=63, createdTime=2022-09-04, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b82e33744f2, moduleTitle=JAMA子刊：推荐局部晚期胃癌患者采用腹腔镜手术治疗，效果优异、并发症少！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b82e33744f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769713, encodeId=eaf11e6971394, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=BMC Cancer：西方真实世界数据为免疫检查点抑制剂在经治转移性胃癌患者的疗效再添证据, objectType=article, longId=294051, objectId=55f229405108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55f229405108, replyNumber=0, likeNumber=37, createdTime=2022-08-25, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55f229405108, moduleTitle=BMC Cancer：西方真实世界数据为免疫检查点抑制剂在经治转移性胃癌患者的疗效再添证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55f229405108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769711, encodeId=48d71e6971162, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=Int J Cancer：Pazopanib +FLO (5-FU，奥沙利铂)一线治疗晚期胃癌患者的疗效和安全性：PaFLO研究, objectType=article, longId=221208, objectId=1c1e22120872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c1e22120872, replyNumber=0, likeNumber=41, createdTime=2022-07-20, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c1e22120872, moduleTitle=Int J Cancer：Pazopanib +FLO (5-FU，奥沙利铂)一线治疗晚期胃癌患者的疗效和安全性：PaFLO研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c1e22120872)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769716, encodeId=d7251e697169c, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=J Gastroenterol：胃癌筛查计划对胃癌患者的长期预后的影响, objectType=article, longId=727116, objectId=ba76e2711603, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba76e2711603, replyNumber=0, likeNumber=51, createdTime=2023-02-16, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba76e2711603, moduleTitle=J Gastroenterol：胃癌筛查计划对胃癌患者的长期预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba76e2711603)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769710, encodeId=ac381e69710c5, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=晚期胃癌患者外周血ERCC1基因多态性与奥沙利铂疗效相关性的研究, objectType=article, longId=221042, objectId=3d7022104236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d7022104236, replyNumber=0, likeNumber=35, createdTime=2022-05-04, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d7022104236, moduleTitle=晚期胃癌患者外周血ERCC1基因多态性与奥沙利铂疗效相关性的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d7022104236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769708, encodeId=0c8d1e69708b2, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=JAMA Surg：腹腔镜vs机器人胃切除术对胃癌患者短期预后的影响, objectType=article, longId=216670, objectId=5b392166e0eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b392166e0eb, replyNumber=0, likeNumber=38, createdTime=2022-01-05, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b392166e0eb, moduleTitle=JAMA Surg：腹腔镜vs机器人胃切除术对胃癌患者短期预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b392166e0eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769707, encodeId=c36b1e6970769, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=The Oncologist：中国胃癌患者不同HER2状态的治疗模式和预后:一项非干预注册研究(EVIDENCE), objectType=article, longId=215442, objectId=6f38215442ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f38215442ba, replyNumber=0, likeNumber=47, createdTime=2022-05-09, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f38215442ba, moduleTitle=The Oncologist：中国胃癌患者不同HER2状态的治疗模式和预后:一项非干预注册研究(EVIDENCE), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f38215442ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769717, encodeId=b7ad1e69717b3, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=ASCO 2022 | 低钠血症可能预示着更糟糕的结果，胃癌患者需警惕！, objectType=article, longId=728527, objectId=9614e28527da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9614e28527da, replyNumber=0, likeNumber=55, createdTime=2023-01-13, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9614e28527da, moduleTitle=ASCO 2022 | 低钠血症可能预示着更糟糕的结果，胃癌患者需警惕！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9614e28527da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769705, encodeId=55171e6970525, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=Clinical Nutrition：身体成分参数可以预测接受新辅助治疗后局部晚期胃癌患者预后, objectType=article, longId=213692, objectId=780621369207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=780621369207, replyNumber=0, likeNumber=40, createdTime=2022-03-25, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=780621369207, moduleTitle=Clinical Nutrition：身体成分参数可以预测接受新辅助治疗后局部晚期胃癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=780621369207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769715, encodeId=56241e6971578, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=JNCCN：生活质量与胃癌患者的预后息息相关！, objectType=article, longId=300617, objectId=649d30061eba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649d30061eba, replyNumber=0, likeNumber=46, createdTime=2022-03-24, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649d30061eba, moduleTitle=JNCCN：生活质量与胃癌患者的预后息息相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=649d30061eba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769703, encodeId=381d1e6970397, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=55岁以上胃癌患者占病患总数7成，如何远离癌症？, objectType=article, longId=212368, objectId=8dd221236836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dd221236836, replyNumber=0, likeNumber=58, createdTime=2022-04-14, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dd221236836, moduleTitle=55岁以上胃癌患者占病患总数7成，如何远离癌症？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dd221236836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769709, encodeId=8c9b1e69709a8, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=Gastric Cancer: 肿瘤标志物和循环肿瘤DNA(ctDNA)在接受围手术期治疗的可切除胃癌患者中的预后价值, objectType=article, longId=219749, objectId=4b7a219e49bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b7a219e49bd, replyNumber=0, likeNumber=39, createdTime=2022-06-25, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b7a219e49bd, moduleTitle=Gastric Cancer: 肿瘤标志物和循环肿瘤DNA(ctDNA)在接受围手术期治疗的可切除胃癌患者中的预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b7a219e49bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769706, encodeId=78471e6970623, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=Cancer Med：研究发现高BMI和既静脉血栓栓塞症史是可切除胃癌患者术前化疗期间发生静脉血栓栓塞症的独立风险因素, objectType=article, longId=214817, objectId=93f621481e06, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93f621481e06, replyNumber=0, likeNumber=43, createdTime=2022-01-18, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93f621481e06, moduleTitle=Cancer Med：研究发现高BMI和既静脉血栓栓塞症史是可切除胃癌患者术前化疗期间发生静脉血栓栓塞症的独立风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93f621481e06)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769702, encodeId=bdee1e6970246, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=Gastric Cancer：Trastuzumab deruxtecan （T-DXd或DS-8201）在HER2阳性胃癌患者的疗效以及安全性管理, objectType=article, longId=211486, objectId=7d0921148685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d0921148685, replyNumber=0, likeNumber=47, createdTime=2021-06-18, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d0921148685, moduleTitle=Gastric Cancer：Trastuzumab deruxtecan （T-DXd或DS-8201）在HER2阳性胃癌患者的疗效以及安全性管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d0921148685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769712, encodeId=bafa1e69712c2, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=BMC Cancer：多中心数据探索nivolumab治疗经治转移性胃癌患者获益的临床预后因素, objectType=article, longId=293706, objectId=27d9293e064d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27d9293e064d, replyNumber=0, likeNumber=46, createdTime=2022-07-25, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27d9293e064d, moduleTitle=BMC Cancer：多中心数据探索nivolumab治疗经治转移性胃癌患者获益的临床预后因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27d9293e064d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769701, encodeId=03f81e6970188, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=EJCN：绿茶的又一功效！加快胃癌患者手术后的康复速度, objectType=article, longId=209055, objectId=2cba2090552f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cba2090552f, replyNumber=0, likeNumber=47, createdTime=2021-04-28, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cba2090552f, moduleTitle=EJCN：绿茶的又一功效！加快胃癌患者手术后的康复速度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cba2090552f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769704, encodeId=74dc1e69704ab, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后, objectType=article, longId=212904, objectId=f025212904a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f025212904a5, replyNumber=0, likeNumber=49, createdTime=2021-07-21, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f025212904a5, moduleTitle=J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f025212904a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769700, encodeId=612f1e6970051, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=Gastric Cancer: PD-1抑制剂治疗的微卫星稳定性胃癌患者少肌症的疗效分析, objectType=article, longId=207970, objectId=547c20e97000, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=547c20e97000, replyNumber=0, likeNumber=43, createdTime=2021-11-21, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=547c20e97000, moduleTitle=Gastric Cancer: PD-1抑制剂治疗的微卫星稳定性胃癌患者少肌症的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=547c20e97000)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1769697, encodeId=521a1e6969770, content=<a href='/topic/show?id=900b8323461' target=_blank style='color:#2F92EE;'>#胃癌患者#</a>, objectTitle=Mol Cancer：无需活检，抽血即可检测，采用免疫治疗的胃癌患者的福音！, objectType=article, longId=204582, objectId=4fe020458242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fe020458242, replyNumber=0, likeNumber=34, createdTime=2021-01-23, rootId=0, userName=huhuaidong400, userId=377c38086944, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fe020458242, moduleTitle=Mol Cancer：无需活检，抽血即可检测，采用免疫治疗的胃癌患者的福音！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fe020458242)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

胃癌患者

2020-05-29

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

BMC Cancer：多中心倾向匹配分析比较术前 vs 术后放化疗治疗局部进展胃癌患者的疗效

2023-02-08

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

JAMA子刊：推荐局部晚期胃癌患者采用腹腔镜手术治疗，效果优异、并发症少！

2022-09-04

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

BMC Cancer：西方真实世界数据为免疫检查点抑制剂在经治转移性胃癌患者的疗效再添证据

2022-08-25

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

Int J Cancer：Pazopanib +FLO (5-FU，奥沙利铂)一线治疗晚期胃癌患者的疗效和安全性：PaFLO研究

2022-07-20

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

J Gastroenterol：胃癌筛查计划对胃癌患者的长期预后的影响

2023-02-16

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

晚期胃癌患者外周血ERCC1基因多态性与奥沙利铂疗效相关性的研究

2022-05-04

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

JAMA Surg：腹腔镜vs机器人胃切除术对胃癌患者短期预后的影响

2022-01-05

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

The Oncologist：中国胃癌患者不同HER2状态的治疗模式和预后:一项非干预注册研究(EVIDENCE)

2022-05-09

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

ASCO 2022 | 低钠血症可能预示着更糟糕的结果，胃癌患者需警惕！

2023-01-13

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

Clinical Nutrition：身体成分参数可以预测接受新辅助治疗后局部晚期胃癌患者预后

2022-03-25

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

JNCCN：生活质量与胃癌患者的预后息息相关！

2022-03-24

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

55岁以上胃癌患者占病患总数7成，如何远离癌症？

2022-04-14

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

Gastric Cancer: 肿瘤标志物和循环肿瘤DNA(ctDNA)在接受围手术期治疗的可切除胃癌患者中的预后价值

2022-06-25

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

Cancer Med：研究发现高BMI和既静脉血栓栓塞症史是可切除胃癌患者术前化疗期间发生静脉血栓栓塞症的独立风险因素

2022-01-18

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

Gastric Cancer：Trastuzumab deruxtecan （T-DXd或DS-8201）在HER2阳性胃癌患者的疗效以及安全性管理

2021-06-18

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

BMC Cancer：多中心数据探索nivolumab治疗经治转移性胃癌患者获益的临床预后因素

2022-07-25

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

EJCN：绿茶的又一功效！加快胃癌患者手术后的康复速度

2021-04-28

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后

2021-07-21

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

Gastric Cancer: PD-1抑制剂治疗的微卫星稳定性胃癌患者少肌症的疗效分析

2021-11-21

huhuaidong400 (审核中...)

前往app查看评论内容

#胃癌患者#

Mol Cancer：无需活检，抽血即可检测，采用免疫治疗的胃癌患者的福音！

2021-01-23

科室
- - 订阅+
  - 更多科室
工具
服务